Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation ACTIVE for mTBI A Targeted Randomized Controlled Trial

What this Trial Is About

Researchers are evaluating a combined therapy called Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation ACTIVE for individuals aged 18 to 49 who have vestibular symptoms related to mild traumatic brain injury mTBI. This trial compares ACTIVE with usual care vestibular rehabilitation VESTIB CONTROL to see which approach better reduces symptoms and improves recovery. The study focuses on military service members and civilians who experience ongoing dizziness and related impairments after mTBI. Participants in the ACTIVE group will receive four weekly 90-minute sessions combining Acceptance and Commitment Therapy ACT and targeted vestibular rehabilitation exercises, along with daily at-home activities over four weeks. The ACT component focuses on psychological flexibility and mindfulness. The comparison group will receive usual care vestibular rehabilitation and other supportive treatments excluding ACT, also delivered weekly over four weeks. Both groups will have individualized care based on their needs. Participants will be assessed before treatment and at 4 weeks, 3 months, and 6 months after treatment ends. Assessments include dizziness severity, anxiety levels, vestibular function tests, symptom questionnaires, and activity monitoring using Fitbit devices. Researchers will monitor symptoms, functional improvements, and return to activity status. The total participation period covers about six months, allowing for evaluation of both short- and longer-term outcomes.

Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT